Comparison 5. Lipid‐lowering agent versus placebo or no treatment.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
5.1 Ipsilateral major or disabling stroke	5	2235	Risk Ratio (M‐H, Random, 95% CI)	0.36 [0.09, 1.53]
5.2 Stroke‐related mortality	2	1366	Risk Ratio (IV, Random, 95% CI)	0.25 [0.03, 2.29]
5.3 Adverse events	7	3726	Risk Ratio (M‐H, Random, 95% CI)	0.76 [0.53, 1.10]